@article {Popma1865, author = {Jan Willem Popma and Frank W. Snel and Cees J. Haagsma and Petra Brummelhuis-Visser and Hans G.J. Oldenhof and Job van der Palen and Mart A.F.J. van de Laar}, title = {Comparison of 2 Dosages of Intraarticular Triamcinolone for the Treatment of Knee Arthritis: Results of a 12-week Randomized Controlled Clinical Trial}, volume = {42}, number = {10}, pages = {1865--1868}, year = {2015}, doi = {10.3899/jrheum.141630}, publisher = {The Journal of Rheumatology}, abstract = {Objective. To determine whether a double dose of intraarticular triamcinolone acetonide is more effective for knee arthritis than a 40-mg dose.Methods. In this 12-week randomized controlled clinical trial, 40 mg and 80 mg of intraarticular triamcinolone acetonide were compared in patients with knee arthritis. Evaluated variables included a Likert burden scale, visual analog scale pain scale, degree of arthritis activity, presence of swelling, and presence of functional limitation.Results. Ninety-seven patients were randomized. No significant differences were observed between the groups regarding any outcomes.Conclusion. An 80-mg dose of triamcinolone acetonide had no additional benefit compared with 40 mg as treatment for knee arthritis. Trial registration: Nederlands Trial Register; trial registration number: NTR2298.}, issn = {0315-162X}, URL = {https://www.jrheum.org/content/42/10/1865}, eprint = {https://www.jrheum.org/content/42/10/1865.full.pdf}, journal = {The Journal of Rheumatology} }